Fundamental dimension Equity attribute | BHBPeer $40.46▲+2.51% Cap $678.4MP/E 12.0x QuantScore56/100 | ACNBLeader $65.42▲+0.05% Cap $665.3MP/E 12.1x QuantScore59/100 | ALRSPeer $32.24▲+0.19% Cap $803.7MP/E 29.3x QuantScore50/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
85/100 |
94/100 |
82/100 |
Valuation Multiples, PEG & DCF upside | 84/100 | 96/100 | 56/100 |
Health Piotroski, Altman Z, leverage & liquidity | 31/100 | 33/100 | 26/100 |
Growth Revenue / earnings growth & margins | 35/100 | 55/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | 44/100 | 20/100 | 55/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 12.0x | 12.1x | 29.3x |
Forward P/E (next FY) | 10.8x | 11.6x | 10.7x |
EV / EBITDA (TTM) | 8.8x | 13.1x | 21.4x |
Price / Sales | 2.9x | 3.3x | 2.4x |
Price / Free Cash Flow | 11.7x | 12.3x | 8.1x |
PEG ratio | 0.27 | 0.19 | -0.98 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 8 / 9 | 6 / 9 |
Altman Z-Score | -0.66 (Distress) | 0.36 (Distress) | 0.22 (Distress) |
Total debt / equity | 0.29 | 0.80 | 0.77 |
Quick ratio | 0.2x | 0.2x | 0.4x |
Interest coverage | 0.8x | 1.8x | 0.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +8.4% | +28.9% | -3.1% |
Net income growth YoY | -15.2% | +16.3% | -1.9% |
Gross margin (TTM) | 68.0% | 79.6% | 72.0% |
Operating margin (FY) | 19.0% | 27.3% | 6.9% |
FCF margin (FY) | 17.9% | 30.9% | 17.9% |
5. Trailing price performancePrice change over period |
1M return | +3.9% | +2.7% | +0.2% |
3M return | +3.7% | +5.3% | -1.4% |
6M return | +17.2% | +33.3% | +26.6% |
Year to date | +30.3% | +35.3% | +43.2% |
1Y return | +35.1% | +46.8% | +50.0% |
3Y return | +69.4% | +104.4% | +84.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $31.20 -22.9% premium | $83.40 +27.5% upside | $6.18 -80.8% premium |
Wall Street consensus target | $46.00 +13.7% · range $44.00–$48.00 | $61.00 -6.8% · range $57.00–$65.00 | $37.00 +14.8% · range $36.00–$38.00 |
Consensus stance | 50% Buy50% Hold0% Sell | 50% Buy50% Hold0% Sell | 40% Buy60% Hold0% Sell |